Cargando…

Hydrogen in Drinking Water Reduces Dopaminergic Neuronal Loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Mouse Model of Parkinson's Disease

It has been shown that molecular hydrogen (H(2)) acts as a therapeutic antioxidant and suppresses brain injury by buffering the effects of oxidative stress. Chronic oxidative stress causes neurodegenerative diseases such as Parkinson's disease (PD). Here, we show that drinking H(2)-containing w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujita, Kyota, Seike, Toshihiro, Yutsudo, Noriko, Ohno, Mizuki, Yamada, Hidetaka, Yamaguchi, Hiroo, Sakumi, Kunihiko, Yamakawa, Yukiko, Kido, Mizuho A., Takaki, Atsushi, Katafuchi, Toshihiko, Tanaka, Yoshinori, Nakabeppu, Yusaku, Noda, Mami
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747267/ https://www.ncbi.nlm.nih.gov/pubmed/19789628 http://dx.doi.org/10.1371/journal.pone.0007247

Ejemplares similares

Therapeutic Effects of Hydrogen in Animal Models of Parkinson's Disease
por: Fujita, Kyota, et al.
Publicado: (2011)

NUDT16 and ITPA play a dual protective role in maintaining chromosome stability and cell growth by eliminating dIDP/IDP and dITP/ITP from nucleotide pools in mammals
por: Abolhassani, Nona, et al.
Publicado: (2010)

Therapeutic Approach to Neurodegenerative Diseases by Medical Gases: Focusing on Redox Signaling and Related Antioxidant Enzymes
por: Fujita, Kyota, et al.
Publicado: (2012)

Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis
por: Seike, Toshihiro, et al.
Publicado: (2010)

Overexpression of Parkin Ameliorates Dopaminergic Neurodegeneration Induced by 1- Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in Mice
por: Bian, Minjuan, et al.
Publicado: (2012)

8-oxoguanine causes spontaneous de novo germline mutations in mice
por: Ohno, Mizuki, et al.
Publicado: (2014)

A functional analysis of the DNA glycosylase activity of mouse MUTYH protein excising 2-hydroxyadenine opposite guanine in DNA
por: Ushijima, Yasuhiro, et al.
Publicado: (2005)

8-Oxoguanine accumulation in mitochondrial DNA causes mitochondrial dysfunction and impairs neuritogenesis in cultured adult mouse cortical neurons under oxidative conditions
por: Leon, Julio, et al.
Publicado: (2016)

Corrigendum: 8-Oxoguanine accumulation in mitochondrial DNA causes mitochondrial dysfunction and impairs neuritogenesis in cultured adult mouse cortical neurons under oxidative conditions
por: Leon, Julio, et al.
Publicado: (2016)

e-Cadherin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson Disease
por: Cataldi, Samuela, et al.
Publicado: (2016)

Anti-parkinsonian effects of octacosanol in 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine-treated mice☆
por: Wang, Tao, et al.
Publicado: (2012)

8-Oxoguanine DNA Glycosylase (OGG1) Deficiency Increases Susceptibility to Obesity and Metabolic Dysfunction
por: Sampath, Harini, et al.
Publicado: (2012)

Deoxyinosine triphosphate induces MLH1/PMS2- and p53-dependent cell growth arrest and DNA instability in mammalian cells
por: Yoneshima, Yasuto, et al.
Publicado: (2016)

Acute Morphine Treatments Alleviate Tremor in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Monkeys
por: Yan, Ting, et al.
Publicado: (2014)

Therapeutic effects of paeonol on methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid-induced Parkinson's disease in mice
por: Shi, Xiaojin, et al.
Publicado: (2016)

Transient dystonia correlates with parkinsonism after 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine in nonhuman primates
por: Norris, S. A., et al.
Publicado: (2023)

Ranbp2 haploinsufficiency mediates distinct cellular and biochemical phenotypes in brain and retinal dopaminergic and glia cells elicited by the Parkinsonian neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
por: Cho, Kyoung-in, et al.
Publicado: (2012)

Ampelopsis Radix Protects Dopaminergic Neurons against 1-Methyl-4-phenylpyridinium/1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Toxicity in Parkinson's Disease Models In Vitro and In Vivo
por: Park, Hanbyeol, et al.
Publicado: (2013)

Dopamine receptor 3 might be an essential molecule in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity
por: Chen, Yan, et al.
Publicado: (2013)

Neuroprotective potential of Quercetin in combination with piperine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity
por: Singh, Shamsher, et al.
Publicado: (2017)

Microglia reaction on the neurotoxic effect of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) in the nigrostriatal pathway in mice
por: Czlonkowska, A., et al.
Publicado: (1994)

Human mitochondrial transcriptional factor A breaks the mitochondria-mediated vicious cycle in Alzheimer’s disease
por: Oka, Sugako, et al.
Publicado: (2016)

Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
por: L'Episcopo, Francesca, et al.
Publicado: (2010)

A high‐fat diet exacerbates the Alzheimer's disease pathology in the hippocampus of the App (NL−F/NL−F) knock‐in mouse model
por: Mazzei, Guianfranco, et al.
Publicado: (2021)

Resveratrol attenuates oxidative stress and improves behaviour in 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) challenged mice
por: Anandhan, Annadurai, et al.
Publicado: (2010)

Isopropyl 1-benzoyl-4-benzoyloxy-2,6-diphenyl-1,2,3,6-tetrahydropyridine-3-carboxylate
por: Govindan, E., et al.
Publicado: (2014)

Pain perception in acute model mice of Parkinson’s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
por: Park, Jihye, et al.
Publicado: (2015)

Korean Red Ginseng Enhances Neurogenesis in the Subventricular Zone of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Mice
por: Ryu, Sun, et al.
Publicado: (2018)

Design, Synthesis and Evaluation of Novel N-Substituted-[Benzoylamino]-5-Ethyl-1,2,3,6-Tetrahydropyridines as Potential Anti-Cancer Agents
por: Henderson, Elizabeth D, et al.
Publicado: (2019)

Comparison of the effect of rotenone and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on inducing chronic Parkinson's disease in mouse models
por: Zhang, Jing, et al.
Publicado: (2022)

Neuroprotective Effects of a Cholecystokinin Analogue in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Parkinson’s Disease Mouse Model
por: Zhang, Zijuan, et al.
Publicado: (2022)

Ganoderma lucidum Modulates Inflammatory Responses following 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) Administration in Mice
por: Ren, Zhili, et al.
Publicado: (2022)

Connexin 30 deficiency attenuates A2 astrocyte responses and induces severe neurodegeneration in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride Parkinson’s disease animal model
por: Fujita, Atsushi, et al.
Publicado: (2018)

Neural stem cell–specific ITPA deficiency causes neural depolarization and epilepsy
por: Koga, Yuichiro, et al.
Publicado: (2020)

MTH1 and OGG1 maintain a low level of 8-oxoguanine in Alzheimer's brain, and prevent the progression of Alzheimer's pathogenesis
por: Oka, Sugako, et al.
Publicado: (2021)

Dispersed Activity during Passive Movement in the Globus Pallidus of the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Treated Primate
por: Erez, Yaara, et al.
Publicado: (2011)

SIRT2 enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced nigrostriatal damage via apoptotic pathway
por: Liu, Lei, et al.
Publicado: (2014)

Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
por: Mounsey, Ross B., et al.
Publicado: (2015)

Dietary curcumin supplementation attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in C57BL mice
por: He, Xi-Jun, et al.
Publicado: (2015)

Mirtazapine has a therapeutic potency in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mice model of Parkinson’s disease
por: Kadoguchi, Naoto, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rt3rcasl7a3grggc7n66r4uuor